Leerink Partners initiated coverage on Vera Therapeutics with a new price target
Leerink Partners initiated coverage of Vera Therapeutics with a rating of Market Perform and set a new price target of $34.00
- TD Cowen initiated coverage on TeraWulf with a new price target
TD Cowen initiated coverage of TeraWulf with a rating of Buy and set a new price target of $21.00
- UBS initiated coverage on Tectonic Therapeutic with a new price target
UBS initiated coverage of Tectonic Therapeutic with a rating of Neutral and set a new price target of $26.00
- UBS initiated coverage on Spyre Therapeutics with a new price target
UBS initiated coverage of Spyre Therapeutics with a rating of Buy and set a new price target of $120.00
- UBS initiated coverage on Shattuck Labs with a new price target
UBS initiated coverage of Shattuck Labs with a rating of Buy and set a new price target of $17.00
- Evercore ISI initiated coverage on Robinhood Markets with a new price target
Evercore ISI initiated coverage of Robinhood Markets with a rating of Outperform and set a new price target of $130.00
- BTIG Research initiated coverage on Quoin Pharmaceuticals with a new price target
BTIG Research initiated coverage of Quoin Pharmaceuticals with a rating of Buy and set a new price target of $14.00
- Leerink Partners initiated coverage on Q32 Bio with a new price target
Leerink Partners initiated coverage of Q32 Bio with a rating of Outperform and set a new price target of $40.00
- UBS initiated coverage on Protagonist Therapeutics with a new price target
UBS initiated coverage of Protagonist Therapeutics with a rating of Buy and set a new price target of $184.00
- UBS initiated coverage on Ocular Therapeutix with a new price target
UBS initiated coverage of Ocular Therapeutix with a rating of Buy and set a new price target of $14.00
- UBS initiated coverage on Nektar Therapeutics with a new price target
UBS initiated coverage of Nektar Therapeutics with a rating of Neutral and set a new price target of $53.00
- Leerink Partners initiated coverage on Nektar Therapeutics with a new price target
Leerink Partners initiated coverage of Nektar Therapeutics with a rating of Outperform and set a new price target of $130.00
- Jefferies initiated coverage on MiniMed with a new price target
Jefferies initiated coverage of MiniMed with a rating of Hold and set a new price target of $22.00
- UBS initiated coverage on Mineralys Therapeutics with a new price target
UBS initiated coverage of Mineralys Therapeutics with a rating of Neutral and set a new price target of $29.00
- Evercore ISI initiated coverage on Interactive Brokers with a new price target
Evercore ISI initiated coverage of Interactive Brokers with a rating of Outperform and set a new price target of $100.00
- KeyBanc Capital Markets initiated coverage on IDEXX Labs
KeyBanc Capital Markets initiated coverage of IDEXX Labs with a rating of Sector Weight
- Truist initiated coverage on Hartford Financial with a new price target
Truist initiated coverage of Hartford Financial with a rating of Hold and set a new price target of $137.00
- Hovde Group initiated coverage on First Financial with a new price target
Hovde Group initiated coverage of First Financial with a rating of Outperform and set a new price target of $85.00
- Leerink Partners resumed coverage on Equillium with a new price target
Leerink Partners resumed coverage of Equillium with a rating of Outperform and set a new price target of $6.00
- UBS initiated coverage on Evommune with a new price target
UBS initiated coverage of Evommune with a rating of Neutral and set a new price target of $8.00